The CIS Aldoctk-125 kit, a direct radioimmunoassay for plasma aldosterone, has been compared with a conventional technique involving solvent extraction. Results given by these two methods were poorly correlated (r = 0,445, n = 103), the direct assay giving higher values, particularly in patients being dialysed for renal failure. When the kit was modified to include an extraction step, results correlated well with those of the standard method (r = 0'952, n = 60).
Early methods for the radioimmunoassay of plasma aldosterone relied for their specificity on a preliminary solvent extraction of the sample followed by chromatography.vs With the development of more specific antisera, chromatographic separation was abandoned by some workers although others considered it advisable to remove lipids to avoid non-specific interference in the assay. 3 Nevertheless the continued use of organic solvents for extracting the steroid, even when chromatography was not performed, prevented complete automation of aldosterone methods, and sample throughput remained low.
A recently introduced commercial kit for the assay of aldosterone of unextracted plasma combines the technical simplicity of the antibody-coated tube with the convenience of an iodine label. The kit method is simple to perform and would enable large numbers of samples to be assayed. This direct assay might, however, lead to falsely high results due to the presence of polar metabolites of aldosterone normally excluded by a solvent extraction step. A conventional aldosterone radioimmunoassay has therefore been compared with the kit in its original ·Correspondence and requests for reprints to Graham D Carter, Chemical Pathology Department, Charing Cross Hospital, Fulham Palace Road, London W6 8RF. form and modified to include a preliminary solvent extraction.
Materials and methods

COLLECTION OF SAMPLES
Blood was taken from healthy volunteers, patients with essential hypertension and normal renal function, and patients with renal failure on longterm intermittent haemodialysis. The latter included a group of anephric patients, some of whom had been given an oral dose (500 flog) of aldosterone 24 hours previously. All samples were taken between 1000 and 1200, with the subjects sitting in an upright position for 10 minutes before venepuncture. The blood was taken into lithium heparin tubes and immediately centrifuged at 4°C, and the plasma was frozen within 10 minites.
REAGENTS
Aldosterone was obtained from Sigma and used without further purification. 1, 2, 6, 7, was obtained from the Radiochemical Centre, Amersham, and purified by descending paper chromatography in the system toluene :methanol :water (500:108:50 vIv). The product was stored at 4°C in methanol.
31%, 5~-tetrahydroaldosterone-l, 2-3H (57'5 54 Ci/mmol) was obtained from New England Nuclear and stored in benzene :methanol (9: 1 vIv) at 4°C. Dicloromethane (Mallinckrodt, nanograde) and methanol (BDH, AnalaR) were distilled before use.
-glucuronidase (Ketodase) was obtained from William Warner & Co, Eastleigh, Hants.
Silica gel (Merck 7734) was purchased from BDH. Phosphate-buffered saline (PBS):O'04M sodium phosphate buffer, pH 7·35, containing 6 gil sodium chloride, 1 gil bovine serum albumin (Bovumin, Ortho Diagnostics), and 1 gil sodium azide (BDH). 18% Albumin solution:180 g bovine serum albumin (30% Pentax, Miles Laboratories), 9 g sodium chloride, 1 g neomycin sulphate (Sigma), and 1 g sodium azide dissolved in distilled water. The pH was adjusted to 7·4 with 1M sodium hydroxide and the volume was made up to 1 I.
Dextran-coated charcoal :250 mg Norit A charcoal Table 1 Summary of assay procedures (Sigma) and 25 mg dextran T-70 (Pharmacia) in 100 ml PBS. Scintillation fluid:80 g butyl-PBD (Packard) in 6 I of scintillation grade toluene (BDH) plus 2 I Triton X-loo (Koch-Light).
Aldosterone antiserum, which was a gift from Dr J K McKenzie (Department of Medicine, University of Manitoba), was raised in a rabbit inoculated with a conjugate of aldosterone 3-oxime and rabbit serum albumin. This was used at an initial dilution of 1 in 5200.
CIS Aldoctk-125 kits for plasma aldosterone were provided by CIS (UK) Ltd.
METHODS FOR THE RADIOIMMUNOASSAY OF PLASMA ALDOSTERONE
A summary of the aldosterone methods used in the investigations is given in Table To I ml plasma, buffered to pH 4· 5 with acetate buffer, was added 200 fl.l of~-glucuronidase. After incubation at 37°C for 24 hours the sample was extracted with 20 ml of dichloromethane and assayed using the CXH method.
of steroids, and the results were calculated according to the method of Abraham." Unfortunately it was not possible to include tetrahydroaldosterone or its 3-glucuronide as these compounds were not available. A summary of the results, together with the kit manufacturer's data for the same steroids, is presented in Table 2 .
PAPER CHROMATOGRAPHY OF HYDROLYSATES
The system used was toluene :methanol :water (500:108:50 vlv). Three millilitres of plasma were treated with 600 fl.l of~-glucuronidaseas described above. After hydrolysis 3H-aldosterone and 3H_ tetrahydroaldosterone (approximately 1000 cpm of each) were added to monitor recovery, and the hydrolysates were extracted with 20 ml dichloromethane. Emulsions were dispersed by the addition of O'IM sodium hydroxide and the phases were separated by centrifugation. The extracts were washed with O·IM acetic acid followed by distilled water and taken to dryness under nitrogen.
The plasma extracts were taken up in methanol: dichloromethane (50:50 vlv) containing a little isatin (an orange dye) and applied to unwashed Whatman No. 2 chromatography paper cut into 2 cm lanes separated by gaps of O' 5 ern, After equilibration overnight in a glass tank lined with filter paper soaked in stationary phase, the mobile phase (toluene) was added, and the chromatogram was developed for 5 hours. A water blank was taken through the entire procedure (including the hydrolysis stage). 3H-Aldosterone and 3H-tetrahydroaldosterone (10000 cpm of each) were run in parallel lanes as markers.
When dry, 0'5 em strips were cut from each marker lane and eluted with methanol. The position of peak radioactivity was used to calculate the distance travelled by each steroid relative to isatin
The method currently used at Charing Cross Hospital is based on that of James and Wilson. 3 One millilitre of plasma was extracted with 8 ml dichloromethane after the addition of approximately 1000 cpm of 3H-aldosterone. The extract was applied to a 5 x 40 mm silica gel column which was then washed with 3 ml dichloromethane :methanol (98:2 v/v). The aldosterone was eluted with 3 ml dichloromethane:methanol (9:1 vtv), and the eluate was dried under a stream of nitrogen at 40°C. The residue was dissolved in 0'5 rnl PBS and left to stand for at least 1 hour. Two 1OD-fl.1 aliquots were taken into 10 x 60 mID plastic assay tubes and 200 fl.l were counted to assess recovery. A standard curve covering the range 0-500 pg/tube was prepared from dilutions of an aldosterone standard in buffer. To all tubes were added 100 fl.l (5000 cpm) ofSH-aldosterone in buffer and 100 fl.l of diluted antiserum. After mixing on a vortex mixer the tubes were incubated at 4°C for 18 hours. Unbound hormone was precipitated by adding 1 rnl of cold dextran-coated charcoal. After mixing the tubes were incubated in an ice-bath for 15 minutes before centrifugation at 2000 rpm for 15 minutes at 4°C. The supernatant was decanted into glass vials containing 13 ml scintillation fluid and counted in a liquid scintillation counter.
CIS Aldoctk-125 kit
The kit was used as directed by the manufacturer. In outline the procedure was: 200 fl.l aliquots of sample or standard were diluted with 700 fl.1 of a phosphate-citrate buffer in antibody-coated tubes using an automated pipetting station (Micromedic Systems Inc). After 100 fl.l of 120I-aldosterone had been added, the tubes were incubated for 18 hours at 4°C. The contents were aspirated and the tubes were rinsed twice with 2 rnl distilled water and counted in an automatic gamma counter.
CIS Aldoctk-125 kit modified to include an extraction step One millilitre of plasma was extracted with 8 ml dichloromethane after the addition of approximately 1000 cpm of 3H-aldosterone to monitor recovery. The extracts were dried in a stream of nitrogen at 40°C, and the residue was redissolved in 1 rnl 18% albumin solution.
Two 200 fl.l aliquots were assayed using the kit and 200 fl.l were counted to assess extraction efficiency. 
Specificity of antisera
Results
COMPARISON OF CIS ALDOCTK-125 KIT WITH THE CXH METHOD
Plasma aldosterone was measured in 103 subjects using the unmodified kit and the CXH method. The results are presented in Figure 1 . The correlation (r) between the values given by the two methods was 0·445 (p<O·ool). Detailed inspection of the results revealed that those patients on dialysis tended to have a higher aldosterone when measured by the kit. This was most noticeable in the anephric patients, particularly in those who had received oral aldosterone.
In the healthy subjects and patients with essential hypertension, there was closer agreement (r = 0,736, p<O·ool; log y = 0·821 log x + 0'49).
(RI). The isatin moved approximately 11 em from the origin, and the RI values for aldosterone and tetrahydroaldosterone were 0·85 and 0·28 respectively. Accordingly, two 3·0 em strips (RI ± 1· 5 em) from each sample lane were eluted with 9·0 rn1 methanol, and the extracts were dried and redissolved in 0'5 ml PBS. Two loo-fLl aliquots were taken for radioimmunoassay (CXH method) and 200 fLl were counted to calculate recovery. Fig. 1 Correlation between plasma aldosterone levels determined by the CIS Aldoctk-125 kit and the routine CXH method: .6. anephric patients; A anephric patients after oral aldosterone; • other patients on haemodialysis; o subjects with normal renal function. 
HYDROLYSIS OF GLUCURONIDES
The possibility that a glucuronide might account for the observed discrepancies was investigated by assaying plasma extracts before and after hydrolysis with~-glucuronidase. Samples were obtained from normal subjects and from patients with renal failure. The latter included an anephric patient who had been given an oral dose (500 fLg) of aldosterone 24 hours previously.
With the CXH method all samples showed an apparent increase in aldosterone after hydrolysis (Table 3) . Although the rise was greatest in the dialysis patient who had received aldosterone, an increase was also observed in the plasma from subjects with normal renal function.
COMPARISON OF A MODIFIED KIT PROCEDURE WITH THE CXH METHOD
In view of the high values given by the direct assay, the kit procedure was modified by introducing a solvent extraction step to exclude polar metabolites.
Samples from 30 normal subjects and 30 dialysis patients were analysed using the modified kit and the CXH method.
As shown in Fig. 2 , when the samples were extracted with an organic solvent, the results obtained with the kit correlated well with those given by the in-house method (r = 0'952, p<O·ool). The most likely source of interference in the direct assay was thought to be tetrahydroaldosterone 3-glucuronide, a major urinary metabolite and one that was likely to cross-react with antisera raised against 3-oxime conjugates. Evidence to support this hypothesis was sought from a further nine dialysis patients, none of whom had received oral aldosterone. Blood was taken just before haemodialysis, and the plasma aldosterone concentration was measured using the unmodified kit and the CXH method. After hydrolysis and paper chromatography the CXH method was used to assay extracts from sections of chromatogram corresponding to aldosterone and tetrahydroaldosterone. 2800  1500  12600  2  520  90  70  390  3  300  <25  30  155  4  335  50  35  485  5  395  35  65  940  6  210  45  65  425  7  195  65  65  405  8  465  390  230  1395  9  970  630  765  3535 ·Measured as aldosterone. tCIS AJdoctk-125 used on unextracted plasma. tThe 'in-house' procedure described in the methods section.
The results obtained before hydrolysis (Table 4 ) confirmed the previous findings; in all cases plasma aldosterone values given by the direct assay (kit) were higher than those obtained with the method involving solvent extractions (CXH method).
After hydrolysis a substance having the chromatographic properties of tetrahydroaldosterone was detected (as aldosterone) by the CXH procedure (Table 4 ). This was found in all samples, but by far the largest amount was found in patient I, whose aldosterone level was also very high, particularly when measured by the direct assay. Although there was no apparent correlation between the tetrahydroaldosterone levels and the degree of interference in the direct assay by the putative 3glucuronide, this may reflect differences in antibody specificity for the two compounds.
Apart from patient 1, whose level fell, aldosterone itself showed no appreciable concentration change after the samples had been treated with~ glucuronidase.
Discussion
The CIS Aldoctk-125 kit, a direct assay for plasma aldosterone, gave higher results than a method incorporating a solvent extraction; the differences were particularly marked in patients with severe renal failure. When the kit procedure was modified to include a solvent extraction step, the results correlated well with those obtained using the indirect assay. These findings suggest that the direct method detects polar compounds which in the conventional assay are excluded by extracting the plasma with an organic solvent.
Jowett and Slater? also reported the consistent overestimation of plasma aldosterone by a direct method and suggested the possibility of interference by a water-soluble conjugate, possibly a 3-glucuronide. These discrepancies have not been reported by other workers.s 6 but validation of their assays involved measurements in patients with normal renal function. The possibility of interference from water-soluble metabolites of aldosterone, if considered, was not investigated, perhaps because of difficulties in obtaining the pure compounds.
Our results confirm that glucuronides of aldosterone or immunologically related compounds are present in plasma and may cause an overestimation of aldosterone by the direct assay, even in normal subjects. In patients with renal failure, retention of these polar conjugates could lead to serious analytical errors.
The interfering glucuronides are likely to include one or both of the two major aldosterone excretory products, aldosterone 18-glucuronide and 3a., 5~ tetrahydroaldosterone 3-glucuronide. The latter derivative was tentatively identified in the plasma of dialysis patients, but failure to detect the 18glucuronide may have been due to its resistance to hydrolysis by mammalian~-glucuronidase.7 Interference from aldosterone 18-glucuronide is in any case unlikely to be a problem as the molecule does not possess the aldehyde group at carbon 18, which is an important antigenic determinant in the aldosterone 3-oxime protein conjugate used to produce the antiserum. On the other hand, structural similarities between the immunogen and tetrahydroaldosterone 3-glucuronide support the experimental evidence that this compound contributes to the high results obtained with the direct assay.
The relevance of these observations to other direct assays is self-evident and is not confined to aldosterone. The omission of a preliminary solvent extraction in any steroid assay may expose the antiserum to unconsidered metabolites whose importance is not diminished by their absence from manufacturers' catalogues. Fortunately for the assayist, ·anephric patients retain polar conjugates, and the examination of a pre-dialysis sample from one or two of these patients appears to be a useful means of testing the specificity of a direct assay.
This investigation has shown that the CIS Aldoctk-I25 kit, when used as a direct assay, is unsuitable for patients with renal failure and may be unreliable for patients with normal renal function. Preliminary extraction of the samples eliminates these problems and, while not quite so convenient, the modified kit retains the considerable advantages of the coated tube and iodine label. The kit, in its modified form, has been used successfully for over a year at Charing Cross Hospital, allowing a sample throughput that could not be matched by the previous method.
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